Huntingtin interacting protein HYPK is intrinsically unstructured

Proteins: Structure, Function and Genetics

Volumn 71, Issue 4, 2008, Pages 1686-1698

  Raychaudhuri, Swasti ^a   Majumder, Pritha ^a   Sarkar, Somosree ^a   Giri, Kalyan ^a   Mukhopadhyay, Debashis ^a   Bhattacharyya, Nitai P ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

Huntington's disease; HYPK; IUP; Pre molten globule; Protein interaction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); HUNTINGTIN; PAPAIN; TRYPSIN;

AMINO ACID ANALYSIS; ARTICLE; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; YEAST;

AMINO ACID SEQUENCE; CALCIUM; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; COMPUTER SIMULATION; CROSS-LINKING REAGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HUNTINGTON DISEASE; HYDROLYSIS; HYDROPHOBICITY; LIGHT; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PAPAIN; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN STRUCTURE, SECONDARY; SCATTERING, RADIATION; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS; TRYPSIN;

EID: 44349119206     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21856     Document Type: Article

References (72)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
2. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science 1997;277:1990-1993.
3. Hickey MA, Chesselet MF. Apoptosis in Huntington's disease. Prog Neuro-Psychopharmacol Biol Psychiatry 2003;27:255-265.
4. Lipinski MM, Yuan J. Mechanisms of cell death in polyglutamine expansion diseases. Curr Opin Pharmacol 2004;4:85-90.
5. Ross CA. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 1997;19:1147-1150.
6. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel JP, Gusella JF, Joyner AL. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995;269:407-410.
7. Nasir J, Floresco SB, ÓKusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995;81:811-823.
8. White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet 1997;17:404-410.
9. Waldmeier PC, Tatton WG. Interrupting apoptosis in neurodegenerative disease: potential for effective therapy? Drug Discov Today 2004;9:210-218.
10. Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S. Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci 2001;24:182-188.
11. Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U, Droege A, Lindenberg KS, Knoblich M, Haenig C, Herbst M, Suopanki J, Scherzinger E, Abraham C, Bauer B, Hasenbank R, Fritzsche A, Ludewig AH, Buessow K, Coleman SH, Gutekunst C, Landwehrmeyer BG, Lehrach H, Wanker EE. A Protein Interaction Network Links GITI, an Enhancer of Huntingtin Aggregation, to Huntington's Disease. Mol Cell 2004;15:853-865.
12. Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A, Strand A, Torcassi C, Savage J, Hurlburt A, Cha GH, Ukani L, Chepanoske CL, Zhen Y, Sahasrabudhe S, Olson J, Kurschner C, Ellerby LM, Peltier JM, Botas J, Hughes RE. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genetics 2007;3:e82(doi:10.1371/journal).
13. Li SH, Li XJ. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 2004;20:146-154.
14. Mitsui K, Nakayama H, Akagi T, Nekooki M, Ohtawa K, Takio K, Hashikawa T, Nukina N. Purification of polyglutamine aggregates and identification of elongation factor-1α and heat shock protein 84 as aggregate-interacting proteins. J Neurosci 2002;22:9267-9277.
15. Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst C, Leavitt BR, Metzler M, Hackam AS, Tam J, Vaillancourt JP, Houtzager V, Rasper M, Roy S, Hayden MR, Nicholson DW. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol 2002;4:95-105.
16. Hattula K, Peranen J. FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol 2000;10:1603-1606.
17. Faber WP, Barnes TG, Srinidhi J, Chen J, Gusella FJ, MacDonald ME. Huntingtin interacts with a family of WW domain proteins. Hum Mol Genet 1998;7:1463-1474.
18. Passani AL, Bedford TM, Faber WP, McGinnis MK, Sharp HA, Gusella FJ, Vonsattel J, MacDonald ME. Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis. Hum Mol Genet 2000;9:2175-2182.
19. Rega S, Stiewe T, Chang D, Pollmeier B, Esche H, Bardenheuer W, Marquitan G, MPützer B. Identification of the full-length Huntingtin-interacting protein p231HBP/HYPB as a DNA-binding factor. Mol Cell Neurosci 2001;18:68-79.
20. Anborgh PH, Godin C, Pampillo M, Dhami KG, Dale BL, Cregan PS, Truant R, Ferguson SGS. Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 2005;280:34840-34848.
21. Huang K, Yanai A, Kang R, Arstikaitis P, Singaraja RR, Metzler M, Mullard A, Haigh B, Gauthier-Campbell C. Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 2004;44:977-986.
22. Cheng Y, LeGall T, Oldfield CJ, Dunker AK, Uversky VN. Abundance of intrinsic disorder in protein associated with cardiovascular disease. Biochemistry 2006;45:10448-10460.
23. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK. Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 2002;323:573-584.
24. Batra-Safferling R, Abarca-Heidemann K, Körschen HG, Tziatzios C, Stoldt M, Budyak I, Willbold D, Schwalbe H, Klein-Seetharaman J, Kaupp UB. Glutamic acid-rich proteins of rod photoreceptors are natively unfolded. J Biol Chem 2006;281:1449-1460.
25. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. In: Walker JM, editors. The proteomics protocols handbook. Totowa, NJ: Humana Press Inc.; 2005. pp 571-607.
26. Uversky VN. Natively unfolded proteins: a point where biology waits for physics. Protein Sci 2002;11:739-756.
27. Li X, Romero P, Rani M, Dunker AK, Obradovic Z. Predicting protein disorder for N-, C-, and internal regions. Genome Inform 1999;10:30-40.
28. Romero P, Obradovic Z, Li X, Garner E, Brown C, Dunker AK. Sequence complexity of disordered protein. Prot Struct Funct Genet 2001;42:38-48.
29. Romero P, Obradovic Z, Dunker AK. Sequence data analysis for long disordered regions prediction in the calcineurin family. Genome Inform 1997;8:110-124.
30. Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, Beckmann JS, Silman I, Sussman JL. FoldIndex©: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 2005;21:3435-3438.
31. Vacic V, Uversky VN, Dunker AK, Lonardi S. Composition profiler: a tool for discovery and visualization of amino acid composition differences. BMC Bioinform 2007;8:211. (doi:10.1186/1471-2105-8-211).
32. Siegel LM, Monty KJ. Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation: application to crude preparations of sulfite and hydroxylamine reductases. Biochim Biophys Acta 1966;112:346-362.
33. Zeev-Ben-Mordehai T, Rydberg EH, Solomon A, Toker L, Auld VJ, Silman I, Botti S, Sussman JL. The intracellular domain of the Drosophila cholinesterase-like neural adhesion protein, gliotactin, is natively unfolded. Prot Struct Funct Genet 2003;53:758-767.
34. Chakraborty A, Das I, Datta R, Sen B, Bhattacharyya D, Mandal C, Datta AK. A single-domain cyclophilin from Leishmania donovani reactivates soluble aggregates of adenosine kinase by isomerase-independent chaperone function. J Biol Chem 2002;277:47451-47460.
35. Bevington P. Data reduction and error analysis in physical sciences. New York: McGraw Hill; 1983.
36. Bhattacharyya K, Basak S. Somatostatin in a water-restricted environment: fluorescence and circular dichroism study in AOT reverse micelles. Photochem Photobiol 1995;62:17-23.
37. Üren A, Tcherkasskaya O, Toretsky JA. Recombinant EWS-FLI1 oncoprotein activates transcription. Biochemistry 2004;43:13579-13589.
38. Permyakov SE, Millett IS, Doniach S, Permyakov EA, Uversky VN. Natively unfolded C-terminal domain of caldesmon remains substantially unstructured after the effective binding to calmodulin. Prot Struct Funct Genet 2003;53:855-862.
39. Fontana A, Zambonin M, Laureto PP, Filippis V, Clementi A, Scaramella E. Probing the conformational state of apomyoglobin by limited proteolysis. J Mol Biol 1997;266:223-230.
40. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN, Dunker AK. Comparing and combining predictors of mostly disordered proteins. Biochemistry 2005;44:1989-2000.
41. 2+ responses of RBL-2H3 mast cells. Mol Biol Cell 1995;6:825-839.
42. 2+ channels in pancreatic beta-cells. J Biol Chem 2001;276:9971-9977.
43. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, Ausio J, Nissen MS, Reeves R, Kang CH, Kissinger CR, Bailey RW, Griswold MD, Chiu W, Garner EC, Obradovic Z. Intrinsically disordered protein. J Mol Graph Model 2001;19:26-59.
44. Pundak S, Roche RS. Tyrosine and tyrosinate fluorescence of bovine testes calmodulin: calcium and pH dependence. Biochemistry 1984;23:1549-1555.
45. Tompa P. Intrinsically unstructured proteins. Trends Biochem Sci 2002;27:527-533.
46. Uversky VN. What does it mean to be natively unfolded? Eur J Biochem 2002;269:2-12.
47. Uversky VN, Yamin G, Munishkin LA, Karymovc MA, Millettd IS, Doniachd S, Lyubchenkoc YL, Fink AL. Effects of nitration on the structure and aggregation of α-synuclein. Mol Brain Res 2005;134:84-102.
48. Otto H, Conz C, Maier P, Wölfle T, Suzuki CK, Jenö P, Rücknagel P, Stahl J, Rospert S. The chaperones MPP11 and Hsp70L1 form the mammalian ribosome-associated complex. Proc Natl Acad Sci 2005;102:10064-10069.
49. Carvalho AF, Costa-Rodrigues J, Correia I, Pessoa JC, Faria TQ, Martins CL, Fransen M, Sá-Miranda C, Azevedo JE. The N-terminal half of the peroxisomal cycling receptor Pex5p is a natively unfolded domain. J Mol Biol 2006;356:864-875.
50. Dyson HJ, Wright PE. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 2005;6:197-208.
51. Bates GP. One misfolded protein allows others to sneak by. Science 2006;311:1385-1386.
52. Tompa P, Szász C, Buday L. Structural disorder throws new light on moonlighting. Trends Biochem Sci 2005;30:484-489.
53. Uversky VN, Gillespie JR, Fink AL. Why are "natively unfolded" proteins unstructured under physiologic conditions? Prot Struct Funct Genet 2000;41:415-427.
54. Dyson HJ, Wright PE. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol 1999;293:321-323.
55. Mukrasch MD, Markwick P, Biernat J, von Bergen M, Bernado P, Griesinger C, Mandelkow E, Zweckstetter M, Blackledge M. Highly populated turn conformations in natively unfolded tau protein identified from residual dipolar couplings and molecular simulation. J Am Chem Soc 2007;129:5235-5243.
56. Lippens G, Sillen A, Smet C, Wieruszeski JM, Leroy A, Buée L, Landrieu I. Studying the natively unfolded neuronal Tau protein by solution NMR spectroscopy. Protein Pept Lett 2006;13:235-246.
57. Brandt R, Hundelt M, Shahani N. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim Biophys Acta 2005;1739:331-354.
58. Syme CD, Blanch EW, Holt C, Jakes R, Goedert M, Hecht L, Barron LD. A Raman optical activity study of rheomorphism in caseins, synucleins and Tau. Eur J Biochem 2002;269:148-156.
59. Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E. Structural studies of Tau protein and Alzheimer paired helical filaments show no evidence for β-structure. J Biol Chem 1994;269:24290-24297.
60. Uversky VN, Li J, Fink AL. Evidence for a partially folded intermediate in α-synuclein fibril formation. J Biol Chem 2001;276:10737-10744.
61. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT. NACP. A protein implicated in Alzheimer's disease and learning is natively unfolded. Biochemistry 1996;35:13709-13715.
62. Bussell R, Eliezer D. Residual structure and dynamics in Parkinson's disease-associated mutants of α-synuclein. J Biol Chem 2001;276:45996-46003.
63. Bussell R, Eliezer D. Effects of parkinson's disease-linked mutations on the structure of lipid-associated α-synuclein Biochemistry 2004;43:4810-4818.
64. Eliezer D, Kutluay E, Bussell R, Browne G. Conformational properties of α-synuclein in its free and lipid-associated states. J Mol Biol 2001;307:1061-1073.
65. Uversky VN. A Protein-chameleon: conformational plasticity of α-synuclein, a disordered protein involved in neurodegenerative disorders. J Biomol Struct Dyn 2003;21:211-234.
66. Chen YW. Local protein unfolding and pathogenesis of polyglutamine- expansion diseases. Prot Struct Funct Genet 2003;51:68-73.
67. Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van YJ, Romero P, Cortese MS, Uversky VN, Dunker AK. Rational drug design via intrinsically disordered protein. Trends Biotech 2006;24:435-442.
68. Kim WY, Fayazi Z, Bao X, Higgins D, Kazemi-Esfarjani P. Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor. Mol Cell Neurosci 2005;29:536-544.
69. Kazemi-Esfarjani P, Benzer S. Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1. Hum Mol Genet 2002;11:2657-72.
70. Hay DG, Sathasivam K, Tobaben S, Stahl B, Marber M, Mestril R, Mahal A, Smith DL, Woodman B, Bates GP. Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 2004;13:1389-1405.
71. Sakahira H, Breuer P, Hayer-Hart MK, Hart FU. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci USA 2002;99:16412-16418.
72. Sickmeier M, Hamilton JA, LeGall T, Vacic V, Cortese MS, Tantos A, Szabo B, Tompa P, Chen J, Uversky VN, Obradovic Z, Dunker AK. DisProt: the database of disordered proteins. Nucleic Acids Res 2007;35:D786-D793.